Visa is acquiring Israeli fraud prevention company BioCatch for 1.3 billion valuation. Permira invested approximately $750 million for a 60% stake. The deal is expected to close by the end of Visa’s fiscal second quarter of 2027, subject to regulatory approvals. BioCatch will continue operating as a standalone business within Visa Value-Added Services per CEO Gadi Mazor (companion Ctech analysis).